Jong-Chan Youn, Darae Kim, Mi-Hyang Jung, Jin-Jin Kim, In-Cheol Kim, Hye Sun Lee, Jin-Oh Choi, Eun-Seok Jeon, Keith Nishihara, Osamu Seguchi, Evan P Kransdorf, David H Chang, Michelle M Kittleson, Jignesh K Patel, Robert M Cole, Jaime D Moriguchi, Danny Ramzy, Fardad Esmailian, Jon A Kobashigawa
BACKGROUND: The risk and benefit of desensitization therapy (DST) in highly sensitized mechanical circulatory support (MCS) patients are not well known. We investigated three year post-transplant outcome of desensitized durable MCS patients. METHODS: Among 689 consecutively enrolled HTx recipients between 2010 and 2016, we categorized them into Group A (desensitized MCS patients, n = 21), Group B (desensitized non-MCS patients, n = 28) and Group C (all non-desensitized patients, n = 640)...
May 5, 2023: Journal of Heart and Lung Transplantation